Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


New acne cream brings new meaning to ‘adding value to dairy’

New acne cream brings new meaning to ‘adding value to dairy’

Hamilton, 16 June 2014 – Hamilton company, Quantec Personal Care, believes Cleopatra may have been onto something when she bathed in milk.

The research focused company has developed a clinically-proven anti-acne cream whose active, patented ingredient is derived from New Zealand cow’s milk.

The company believes this breakthrough skincare product, marketed under the Epiology brand, is a world first in its category and represents an entirely new approach to improving acne and problem skin.

Quantec founder and Managing Director, Dr Rod Claycomb, explains, “The bioactive enzymes and proteins found in our Epiology anti-acne cream are essentially the same active enzymes and proteins that all mammals produce to protect themselves from potentially harmful bacteria and other microorganisms.

“These enzymes and proteins all work together and make up the essential components of the body’s immune defence system. They naturally occur and provide a protective function in saliva and around gums, tears, raw milk and throughout the gut. This raw ingredient – which we call IDP® - is the key component of the Epiology acne cream.”

He says IDP® has unique properties which makes it very powerful against certain types of disease-causing bacteria. When applied to the skin, it leaves the natural and beneficial bacteria of the skin largely unaffected.

“By leaving these natural and beneficial bacteria active on the skin, IDP® creates an ideal scenario for management of acne. In addition, these bio-proteins interact with inflamed tissues and cells to help quell the inflammatory response, which is a primary cause of acne,” said Dr Claycomb.

It has taken the Quantec research and development team seven years to create IDP® and now prove its efficacy for acne.

During 2012 Quantec completed randomised, double-blinded trials on 84 subjects with mild to moderate acne in the United States. The performance of the milk-ingredient based Epiology cream was compared against two other formulations with FDA-approved acne active ingredients: a leading US retail brand of acne product containing 2% salicylic acid plus retinol and another salicylic acid-based formulation.

After six weeks, both the leading US brand and Epiology demonstrated exactly the same results in reducing acne lesions. However, the Epiology cream demonstrated superior results in the overall reduction of acne related redness and inflammation.

“Our clinical trial results demonstrated the benefits of using Epiology acne cream as a new product for acne prone skin. The study showed Epiology provided subjects with a clearer and brighter complexion without irritation or redness and is particularly suitable for those with sensitive skin,” explained Dr Claycomb.

The Epiology range of products is being sold in pharmacies throughout New Zealand.

About Quantec Ltd and Quantec Personal Care Ltd
Based at the Waikato Innovation Park in Hamilton, New Zealand, Quantec Personal Care Ltd is a wholly owned subsidiary of Quantec Ltd and was established in 2013, to commercialise innovative new consumer products that use IDP® as their active ingredient. Epiology Skincare is the first product range to be launched.

Quantec Ltd is a company specialising in the discovery and commercialisation of high-value bioactives from natural products. Quantec discovered and patented its novel milk fraction, comprised of native immune defense proteins (IDP®) that has proven antimicrobial and anti-inflammatory properties. The research and development team at Quantec Ltd is continually investigating new uses for IDP® in both human and animal applications.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Interest Rates: RBNZ Hikes OCR To 3.5%, ‘Period Of Assessment’ Now Needed

Reserve Bank governor Graeme Wheeler raised the official cash rate as expected, while signalling a pause in rate hikes to assess the impact of moves so far this year. The kiwi dollar sank after Wheeler said its strength was “unjustified” and that the currency could have “a significant fall.” More>>

ALSO:

Fonterra: Canpac Site 'Resize' To Focus More On Paediatrics

Fonterra is looking at realigning its packing operations at Canpac, in the Waikato, to focus more on paediatric nutritionals... The proposed changes could mean around 110 roles may not be required at the site which currently employs 330. More>>

ALSO:

Scoop Business: Postie Plus Brand Gets 2nd Chance With Well-Funded Pepkor

The Postie Plus brand is getting a new lease of life after South Africa’s Pepkor bought the failed retailer’s assets out of administration and said it will use its purchasing power to reduce costs of stock and fatten margins. More>>

ALSO:

Warming: Warming Signs From State Of Climate Report

Climate data from air, land, sea and ice in 2013 'reflect trends of a warming planet' -- says the latest State of the Climate report, launched by U.S. and New Zealand scientists. More>>

ALSO:

Scoop Business: Embrace Falling Home Affordability, Says NZIER

Despair over the inability to afford a house is misplaced and should be embraced as an opportunity to invest in more wealth-creating activity, says the principal economist at the New Zealand Institute of Economic Research, Shamubeel Eaqub. More>>

Productivity Commission: NZ Regulation Not Keeping Pace

New Zealand regulators often have to work with out-of-date legislation, quality checks are under strain, and regulatory workers need better training and development. More>>

ALSO:

Callaghan Innovation: Investment To Help Deepen Innovation Reporting

Callaghan Innovation, the government’s high tech HQ for Kiwi business, is to help deepen New Zealand media coverage of the commercialisation of innovation through an arms-length partnership with independent business news service BusinessDesk. More>>

ALSO:

Tax Credits, Grants: Greens $1Bn R&D Plan

In the Party’s headline economic announcement, the Greens have launched their plan to build a smarter, more innovative economy which has as its centrepiece an additional $1 billion of government investment in research and development (R&D) above current spend, including tax breaks for business. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news